This observation is in parallel with the results of our prior studies using a Sox2 reporter (SRR2) in breast cancer cells, wherein no reporter activity was observed in the SRR2-negative subset after Sox2 overexpression [29]. This evidence concerns the gene SOX2 and breast cancer.